Direct-acting antivirals ombitasvir / paritaprevir / ritonavir + dasabuvir with or without ribavirin in hepatitis C virus (HCV) genotype 1-infected treatment-naive or treatment-experienced patients with or without cirrhosis: Real-life experience in Lithuania and Latvia
Ligita Jancoriene, Katazyna Polubenko, Edita Kazenaite, Arida Buivydiene, Jolita Jakutiene, Ieva Tolmane, Agita Jeruma, Daiva Radzisauskiene, Evelina Mockiene, Arvydas Ambrozaitis
Research output: Contribution to journal › Article › peer-review
3Citations
(Scopus)
11Downloads
(Pure)
Fingerprint
Dive into the research topics of 'Direct-acting antivirals ombitasvir / paritaprevir / ritonavir + dasabuvir with or without ribavirin in hepatitis C virus (HCV) genotype 1-infected treatment-naive or treatment-experienced patients with or without cirrhosis: Real-life experience in Lithuania and Latvia'. Together they form a unique fingerprint.